Faithward Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Buy
3,854
+990
+35% +$95K 0.04% 243
2026
Q1
$297K Buy
2,864
+66
+2% +$7.48K 0.04% 225
2025
Q4
$282K Buy
2,798
+394
+16% +$42.8K 0.04% 270
2025
Q3
$296K Buy
2,404
+101
+4% +$12.5K 0.04% 244
2025
Q2
$277K Buy
2,303
+12
+0.5% +$1.6K 0.04% 226
2025
Q1
$337K Hold
2,291
0.06% 198
2024
Q4
$372K Sell
2,291
-13
-0.6% -$2.13K 0.06% 184
2024
Q3
$375K Sell
2,304
-7
-0.3% -$1.04K 0.07% 198
2024
Q2
$315K Buy
2,311
+963
+71% +$134K 0.06% 204
2024
Q1
$206K Buy
+1,348
New +$201K 0.04% 244
2023
Q2
Sell
-1,581
Closed -$268K 279
2023
Q1
$268K Buy
+1,581
New +$237K 0.06% 155

Other funds holding CLX

Faithward Advisors's CLX Position: Q2 2026 in Review

Faithward Advisors increased its Clorox (CLX) stake by 35% in Q2 2026, buying an estimated $95K and bringing the position to 3,854 shares worth $368K. The position accounts for 0.04% of the portfolio, ranked #243.

Faithward Advisors first reported a position in CLX in Q1 2023 and has held it in 11 quarters since. The position peaked at $375K in Q3 2024. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Faithward Advisors held 3,854 shares of Clorox worth $368K as of Q2 2026.
  • Faithward Advisors bought 990 Clorox shares in Q2 2026, an estimated $95K.
  • Clorox made up 0.04% of Faithward Advisors's portfolio in Q2 2026, its #243 holding.
  • Faithward Advisors first reported a position in Clorox in Q1 2023 and has held it in 11 quarters since.
  • Faithward Advisors's Clorox position peaked at $375K in Q3 2024.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.